Q Squared Solutions supplier risk profile Q1 2026: Mexico-focused pharma importer, 60 shipments, 7 suppliers.
Q Squared Solutions imported 60 shipments in Q1 2026 across 7 suppliers, all based in Mexico. The company's sourcing is entirely concentrated in a single country, with Mexico accounting for 100% of shipments. Pharmaceutical products dominate the footprint, with HS chapter 30 (Pharmaceutical products) representing the largest category alongside HS code 980100 (Clinical supplies), which accounts for 29 shipments. Top suppliers include Merck Sharp Dohme Comercializadora (20 shipments) and RS Clinical Research Solutions Mexico (17 shipments).
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Q Squared Solutions shows no sanctions watchlist matches and no suppliers register forced-labor exposure under UFLPA proximity indicators. The importer's supplier risk score is 69, graded C.
7 distinct tier-1 suppliers in Q1 2026
| MERCK SHARP DOHME COMERCIALIZADORA | Mexico | 20 |
| RS CLINICAL RESEARCH SOLUTIONS MEXICO | Mexico | 17 |
| QUINTILES MEXICO | Mexico | 10 |
| PAREXEL MEXICO | Mexico | 6 |
| INTERNACIONAL LATINOAMERICANA DE SERVICIOS | Mexico | 5 |
| NOVO NORDISK MEXICO | Mexico | 1 |
| INFINITE CLINICAL RESEARCH | Mexico | 1 |
Share of Q1 2026 inbound shipments by source country
18 tier-2 + 170 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.